Sunday, September 25, 2022
wellness India Expo
Home Tags Vaccine

Tag: Vaccine

A drop of blood can now determine if a booster dose...

SMART and NTU Singapore develop a quick test kit to determine a person’s immunity against COVID-19 and its variants

Pfizer initiates Phase 3 Study of mRNA-based Influenza vaccine

First Phase 3 efficacy study to be conducted using an mRNA-based influenza vaccine; study will enroll 25,000 U.S. adults 18 years and older

Indonesia’s Bio Farma ready to produce IndoVac Covid-19 vaccines

The company collaborated with Baylor College of Medicine, a private, independent health sciences centre in Houston, Texas to develop IndoVac, a recombinant protein subunit vaccine produced from yeast

Intravacc releases more data on its intranasal SARS-CoV-2 vaccine candidate

Additional pre-clinical data of Avacc 10®indicate reduction in upper respiratory tract viral load and cross neutralization of variants of concern

AstraZeneca likely to see substantial Evusheld uptake in Japan, says GlobalData

The government’s decision to limit the drug’s supply to only COVID-19 prevention will still likely encourage its uptake, says GlobalData, a leading data and analytics company

Bharat Biotech’s iNCOVACC, world’s first Intra Nasal vaccine, gets emergency use...

Heterologous booster dose studies were conducted for safety and immunogenicity in ~875 subjects at 9 trial sites across India

Aurobindo Pharma to invest Rs 300 crore on mammalian cell culture...

The Board also decided that Auro Vaccines will explore the possibilities of offering contract manufacturing to global vaccine developers

CDSCO nod to Biological E’s pneumonia vaccine for infants

BE’s PCV14 is comparable in terms of serotype coverage for infants to the two pneumococcal conjugate vaccines Prevnar13 and Merck’s VAXNEUVANCE, which are currently approved globally

Daiichi Sankyo initiates phase 3 trial of mRNA based covid vaccine

The trial is an active-controlled, trial to investigate the non-inferiority of DS-5670 to an already-approved mRNA vaccine

First ‘Made in India’ cervical cancer vaccine in offing

It will be administered with a two-dose schedule for girls in the age group of 9-14 and a three-dose schedule for girls and women in the age group of 15-26